Urgent.News

What's breaking now, across thousands of outlets.

Business

SK Chemicals expands SKYPEL use from pillows to mattresses

SK Chemicals is expanding the use of its SKYPEL specialty material from pillows to mattresses, replacing conventional olefin-based materials used in bedding fillings. The company said Tuesday that it signed a memorandum of understanding with DMOA, the flagship brand of bedding specialist SENSE MOM, on Monday at SENSE MOM’s headquarters in Incheon's Namdong District. Under the agreement, the two…

SK Chemicals expands SKYPEL use from pillows to mattresses

SK Chemicals is broadening the application of its SKYPEL specialty material from pillows to mattresses, swapping out traditional olefin-based materials typically used in bedding fillings. The company announced a memorandum of understanding on Monday with DMOA, the main brand of bedding brand SENSE MOM, during a signing ceremony at SENSE MOM's main office in Incheon's Namdong District.

Together, SK Chemicals and DMOA aim to innovate and produce pillows, cushions, seat cushions, and mattresses utilizing SKYPEL as a breathable cushion filler. Both firms have already kickstarted the manufacturing of DMOA pillows containing SKYPEL, with plans to further integrate this material into seat cushions and mattresses. For the pillow project, SK Chemicals replaced olefin-based materials like polyolefin elastomer with SKYPEL, a thermoplastic polyester elastomer.

This material functions as a fiberfill akin to cotton wadding, offering a soft touch while retaining its physical attributes in indoor settings with conventional underfloor heating, where products encounter relatively elevated temperatures.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at koreatimes.co.kr →

More in Business

K-Bio Licensing Deals Top $12 Billion, Near Record High

South Korea's pharmaceutical and biotech industry is on track to set a new annual record for overseas licensing deals, with the cumulative value of deals signed by domestic companies this year…

  • K-Bio licensing deals surpass $12 billion, nearing record high
  • Hanmi Pharmaceutical signs $2.3B obesity drug deal with Genentech
  • Korean biotech startups increase licensing activity to $625M

Korea Targets 100 GW of Renewable Energy by 2030

South Korea has unveiled a detailed plan to expand the country's renewable energy capacity to 100 gigawatts by 2030, as securing a stable supply of renewable power emerges as a key factor in the…

  • South Korea aims to reach 100 GW renewable energy capacity by 2030.
  • Government to discuss strategy with industry leaders at August 26 roundtable.
  • Plans include simplifying permitting, new market structure, and grid upgrades.

SK hynix Union Rejects Tentative Labor Deal by 25 Votes

SK hynix's tentative wage and collective bargaining agreement was rejected by just 25 votes, sending the company and its union back to the negotiating table.

  • SK hynix union rejects tentative labor deal by 25 votes
  • 50.08% of 16,083 members voted against the agreement
  • Workers concerned about shift from cash-based compensation system

More from Tuesday 25 August →